DOCS
Tiny sale, big eyeballs
When a CEO files a Form 4, investors tend to squint at it like it’s a suspicious text from their ex. In this case, Doximity’s co-founder and CEO disposed of 8,505 shares for roughly $211,000 based on transaction-date pricing.
Should you panic?
Probably not based on size alone. That’s a relatively small sale compared with a CEO’s overall stake at a company like Doximity, so it doesn’t automatically scream “something’s wrong.” But insider selling always gets attention because executives usually know their own business better than anyone else.
What investors should watch
A one-off sale can be totally mundane — taxes, diversification, a new boat named "Healthcare SaaS". The more important question is whether this becomes a pattern:
- multiple insider sales in a short span
- sales that are large relative to holdings
- any fresh slowdown in growth or guidance
Big picture: this is more of a yellow flag than a siren. On its own, it’s a blip — but if Doximity insiders keep heading for the exit, investors may want to ask why.